Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hospital Medicine
Hemostasis
Questions discussed in this category
Should platelet transfusions be considered for anti-platelet agent reversal in patients with major bleeding?
2 Answers available
In massive transfusion protocol from suspected hemorrhage, is it worth obtaining a TEG to guide transfusion?
1 Answer available
Would you use PCC for clotting factor repletion in acute life threatening hemorrhage in a patient with elevated INR from coagulopathy of liver disease?
2 Answers available
Is there a role for anti-fibrinolytic agents in patients with hyperfibrinolytic disseminated intravascular coagulation?
The use of anti-fibrinolytics is typically contraindicated in DIC, but does it have benefit in DIC states characterized by hyperfibrinolysis?
1 Answer available
8566
13879
15988
9365
Papers discussed in this category
Lancet, 2016 May 10
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
Lancet (London, England), 2010-07-03
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
J Intensive Care, 2014 Feb 20
Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines.
Hematology. American Society of Hematology. Education Program, 2015
Coagulopathy in liver disease: a balancing act.
Related Topics in Hospital Medicine
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers